21 July 2020 · This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing Tissue Engineered Products.
14 July 2020 · Principles to be considered are outlined for Patient Group Directions used in the provision of medicines/vaccines in services provided by multiple organisations
24 February 2020 · This document clarifies the regulatory expectation regarding OOS ATMPs and advises hospitals on Governance in the event of an OOS ATMPs being offered for use.
8 January 2020 · A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012
20 December 2019 · Compiled and Maintained by NHS Pharmaceutical Quality Assurance Committee (Medical Gas Sub-Group) “Only individuals who have been appointed to the Quality Controller (MGPS) register may…
19 December 2019 · This document is intended for multi-professional clinical practitioners to use as a reference and source of information for the prescribing, reconstituting or administering injectable medicines.…